Assessing Risk of Cardiac and Pulmonary Toxicity Profiles in VMAT Compared with 3DCRT for Esophageal Cancer
Vimal Raj. K, Sandesh B Rao, Krishnaraj H.K, Lanisha Sequeira, Sridhar C.H, Tony Jacob, Zalfa Abdul Azeez, Yashmihta Kotian & Shylvea Shalom · Asian Oncology Research Journal · 2025
Background: According to multiple studies, when RT is administered to any thoracic cancer, pulmonary toxicities are far more common than cardiac toxicities. Both acute and chronic cardiac toxicities are possible; the latter can build over the course of a year and cause confusion...